BULL PHARMA: RISKS AND REALITIES

The rise of “rogue pharma” companies presents certain concerning risks to consumer health, but the picture is often more complex than early reports suggest. These entities , frequently operating outside standard regulatory frameworks, may offer competing therapies at lower costs, appealing to mar